Paid Clinical Trials in Fairway, KS

As of September 2026, 76 paid clinical trials are recruiting in Fairway, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

73 clinical trials

Get a weekly email when new trials open in Fairway, KS.

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

for Locally Advanced Pancreatic Adenocarcinoma

Drug: Peposertib

Sites in Fairway, Kansas City +26 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04172532·Phase 1, Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

Sites in Fairway, Kansas City +39 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting·Listed Jan 2019

Apply to this trial

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

Sites in Fairway +26 more locations

Sponsor: Beat AML, LLC

Sex: All·Age: 18+

Code: NCT03013998·Phase 2, Phase 3·Recruiting·Listed Jan 2017

Apply to this trial

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for Acute Myeloid Leukemia

Sites in Fairway, Kansas City +19 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 75

Code: NCT05886049·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for Advanced Malignant Solid Neoplasm

Sites in Fairway, Kansas City +13 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05691491·Phase 1, Phase 2·Recruiting·Listed Jan 2023

Apply to this trial

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

for Advanced Solid Tumors

Sites in Fairway +1 more location

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 12 - 120

Code: NCT04222413·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

for Metastatic Colorectal Adenocarcinoma

Drug: Bevacizumab

Sites in Fairway, Kansas City +11 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06696768·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

for Burkitt Lymphoma

Drug: Pidnarulex

Sites in Fairway, Kansas City +6 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07069699·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for Recurrent Lung Non-Small Cell Carcinoma

Drug: Cemiplimab

Sites in Fairway, Kansas City +379 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06616584·Phase 2, Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

for Breast Cancer

Sites in Fairway +2 more locations

Sponsor: Reshma L. Mahtani, D.O.

Sex: All·Age: 18+

Code: NCT06263543·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for Recurrent Lung Non-Small Cell Carcinoma

Sites in Fairway, Kansas City +239 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18 Minutes+

Code: NCT06031688·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for Lung Non-Small Cell Carcinoma

Sites in Fairway, Kansas City +241 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

for Breast Cancer

Sites in Fairway, Kansas City +6 more locations

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18+

Code: NCT07220135·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for Extensive Stage Lung Small Cell Carcinoma

Sites in Fairway, Kansas City +144 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06769126·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

for Congenital Myotonic Dystrophy

Sites in Fairway +3 more locations

Sponsor: Virginia Commonwealth University

Sex: All·Age: Up to 59 Months

Code: NCT05224778·Recruiting·Listed Feb 2022

Apply to this trial

A Study of Ranolazine in ALS

for Amyotrophic Lateral Sclerosis

Sites in Fairway, Wichita +4 more locations

Sponsor: Swathy Chandrashekhar, MBBS

Sex: All·Age: 18+

Code: NCT06527222·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

for Type2Diabetes

Sites in Fairway +35 more locations

Sponsor: Brigham and Women's Hospital

Sex: All·Age: 40 - 80

Code: NCT05390892·Phase 4·Recruiting·Listed May 2022

Apply to this trial

Nutrition OUtReach In Systems of Healthcare

for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Sites in Fairway +3 more locations

Sponsor: University of Kansas Medical Center

Sex: All·Age: 8 - 80

Code: NCT06802406·Recruiting·Listed Jan 2025

Apply to this trial

Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined

for Myelofibrosis，MF

Drug: Pacritinib

1 location in Fairway

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06414681·EARLY_Phase 1·Recruiting·Listed May 2024

Apply to this trial

MAGIC Ruxolitinib for aGVHD

for Acute Graft-versus-host Disease

Drug: Ruxolitinib

Sites in Fairway +13 more locations

Sponsor: John Levine

Sex: All·Age: 18+

Code: NCT06936566·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

for NSCLC Stage IV

Drug: Atezolizumab

Sites in Fairway & Kansas City

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18+

Code: NCT04467723·Phase 1, Phase 2·Recruiting·Listed Jul 2020

Apply to this trial

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

for Alzheimer Disease

1 location in Fairway

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18 - 100·Accepts healthy volunteers

Code: NCT06728436·Recruiting·Listed Dec 2024

Apply to this trial

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

for Generalized Myasthenia Gravis

Sites in Fairway +1 more location

Sponsor: University of Missouri-Columbia

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06064695·Recruiting·Listed Oct 2023

Apply to this trial

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

for Lung Cancer

Sites in Fairway & Kansas City

Sponsor: Jun Zhang, MD, PhD

Sex: All·Age: 18 - 110

Code: NCT05332925·Recruiting·Listed Apr 2022

Apply to this trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for Gastroesophageal Adenocarcinoma

Sites in Fairway +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07069712·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

for Acute Myeloid Leukemia, Adult

Drug: Venetoclax

Sites in Fairway +13 more locations

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All·Age: 18+

Code: NCT06652438·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for Accelerated Phase Myeloproliferative Neoplasm

Drug: Iadademstat

Sites in Fairway, Kansas City +29 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06661915·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

for Systemic Sclerosis

Sites in Fairway +14 more locations

Sponsor: Nkarta, Inc.

Sex: All·Age: 18 - 75

Code: NCT06733935·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

for Ovarian Cancer

Sites in Fairway +3 more locations

Sponsor: Persevere Therapeutics Inc.

Sex: Female·Age: 18+

Code: NCT03854110·Phase 1·Recruiting·Listed Feb 2019

Apply to this trial

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for Solid Tumors

Sites in Fairway +16 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06431594·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for Delayed Graft Function

Sites in Fairway +29 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06830798·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for Polymyositis, Dermatomyositis

Sites in Fairway +33 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 75

Code: NCT06455449·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial